| Trial of a paclitaxel-coated balloon for femoropopliteal artery disease K Rosenfield, MR Jaff, CJ White, K Rocha-Singh, C Mena-Hurtado, ... New England Journal of Medicine 373 (2), 145-153, 2015 | 690 | 2015 |
| Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results … G Tepe, J Laird, P Schneider, M Brodmann, P Krishnan, A Micari, ... Circulation 131 (5), 495-502, 2015 | 672 | 2015 |
| Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA JR Laird, PA Schneider, G Tepe, M Brodmann, T Zeller, C Metzger, ... Journal of the American College of Cardiology 66 (21), 2329-2338, 2015 | 378 | 2015 |
| Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ... Journal of the American College of Cardiology 58 (15), 1569-1577, 2011 | 327 | 2011 |
| Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies P Krishnan, P Faries, K Niazi, A Jain, R Sachar, WB Bachinsky, ... Circulation 136 (12), 1102-1113, 2017 | 215 | 2017 |
| Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN. PACT SFA randomized trial PA Schneider, JR Laird, G Tepe, M Brodmann, T Zeller, D Scheinert, ... Circulation: Cardiovascular Interventions 11 (1), e005891, 2018 | 208 | 2018 |
| Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions: five-year outcomes from the IN. PACT SFA randomized trial JA Laird, PA Schneider, MR Jaff, M Brodmann, T Zeller, DC Metzger, ... Circulation: Cardiovascular Interventions 12 (6), e007702, 2019 | 135 | 2019 |
| Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials G Dangas, D O'Connor, B Firwana, S Brar, S Ellozy, A Vouyouka, ... JACC: Cardiovascular Interventions 5 (10), 1071-1080, 2012 | 135 | 2012 |
| Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca++ trial D Roberts, K Niazi, W Miller, P Krishnan, R Gammon, T Schreiber, ... Catheterization and Cardiovascular Interventions 84 (2), 236-244, 2014 | 127 | 2014 |
| COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review JS Suri, A Puvvula, M Biswas, M Majhail, L Saba, G Faa, IM Singh, ... Computers in biology and medicine 124, 103960, 2020 | 116 | 2020 |
| Morbidity and mortality after anaesthesia in early life: results of the European prospective multicentre observational study, neonate and children audit of anaesthesia practice … N Disma, F Veyckemans, K Virag, TG Hansen, K Becke, P Harlet, ... British journal of anaesthesia 126 (6), 1157-1172, 2021 | 114 | 2021 |
| IN. PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral … G Tepe, J Laird, P Schneider, M Brodmann, P Krishnan, A Micari, ... Circulation 131 (5), 495-502, 2015 | 98 | 2015 |
| A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an … R Mehran, R Owen, M Chiarito, U Baber, S Sartori, D Cao, J Nicolas, ... The Lancet 398 (10315), 1974-1983, 2021 | 97 | 2021 |
| Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: findings from a large multiethnic registry RS Copeland‐Halperin, U Baber, M Aquino, A Rajamanickam, S Roy, ... Catheterization and Cardiovascular Interventions 91 (5), 859-866, 2018 | 97 | 2018 |
| Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention P Guedeney, BE Claessen, DN Kalkman, M Aquino, S Sorrentino, ... Journal of the American College of Cardiology 73 (19), 2401-2409, 2019 | 89 | 2019 |
| Female gender and mortality after percutaneous coronary intervention: results from a large registry JC Kovacic, R Mehran, R Karajgikar, U Baber, J Suleman, MC Kim, ... Catheterization and Cardiovascular Interventions 80 (4), 514-521, 2012 | 76 | 2012 |
| Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE): a prospective European multicentre … N Disma, K Virag, T Riva, J Kaufmann, T Engelhardt, W Habre, ... British journal of anaesthesia 126 (6), 1173-1181, 2021 | 74 | 2021 |
| Outcome of intracoronary stenting after failed maximal medical therapy in patients with symptomatic myocardial bridge PB Kunamneni, S Rajdev, P Krishnan, PR Moreno, MC Kim, SK Sharma, ... Catheterization and Cardiovascular Interventions 71 (2), 185-190, 2008 | 74 | 2008 |
| A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence JS Suri, S Agarwal, SK Gupta, A Puvvula, M Biswas, L Saba, A Bit, ... Computers in Biology and Medicine 130, 104210, 2021 | 71 | 2021 |
| Mortality assessment of paclitaxel-coated balloons: patient-level meta-analysis of the ILLUMENATE clinical program at 3 years WA Gray, MR Jaff, SA Parikh, GM Ansel, M Brodmann, P Krishnan, ... Circulation 140 (14), 1145-1155, 2019 | 68 | 2019 |
